Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Garadacimab-gxii in Idiopathic Pulmonary Fibrosis: NCT05130970 Clinical Landscape Report 2026
16 October 2026
NCT05130970 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Trehalose in Amyotrophic Lateral Sclerosis: NCT05136885 Clinical Landscape Report 2026
16 October 2026
NCT05136885 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
ZSP-1603 in Idiopathic Pulmonary Fibrosis: NCT05119972 Clinical Landscape Report 2026
16 October 2026
NCT05119972 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Denecimig in Hemophilia A: NCT05127473 Clinical Landscape Report 2026
16 October 2026
NCT05127473 clinical landscape for Hemophilia A: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
RXC-006 in Idiopathic Pulmonary Fibrosis: NCT05134727 Clinical Landscape Report 2026
16 October 2026
NCT05134727 clinical landscape for Idiopathic Pulmonary Fibrosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Concizumab-mtci in Hemophilia B: NCT05135559 Clinical Landscape Report 2026
16 October 2026
NCT05135559 clinical landscape for Hemophilia B: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Hydroxycarbamide in Priapism: NCT05142254 Clinical Landscape Report 2026
16 October 2026
NCT05142254 clinical landscape for Priapism: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Marstacimab-hncq in Hemophilia B: NCT05145127 Clinical Landscape Report 2026
16 October 2026
NCT05145127 clinical landscape for Hemophilia B: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Terazosin Hydrochloride in Amyotrophic Lateral Sclerosis: ISRCTN45028842 Clinical Landscape Report 2026
16 October 2026
ISRCTN45028842 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Damoctocog Alfa Pegol in Hemorrhage: NCT05147662 Clinical Landscape Report 2026
16 October 2026
NCT05147662 clinical landscape for Hemorrhage: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Edaravone in Amyotrophic Lateral Sclerosis: NCT05151471 Clinical Landscape Report 2026
16 October 2026
NCT05151471 clinical landscape for Amyotrophic Lateral Sclerosis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
VGB-R04 in Hemophilia B: NCT05152732 Clinical Landscape Report 2026
16 October 2026
NCT05152732 clinical landscape for Hemophilia B: endpoints, sponsor, phase, geography, readouts, asset context and development white space.